1. Boerman OC, van Schaijk FG, Oyen WJ, Corstens FH (2003) Pretargeted radioimmunotherapy of cancer: progress step by step. J Nucl Med 44:400–411
2. Gruaz-Guyon A, Raguin O, Barbet J (2005) Recent advances in pretargeted radioimmunotherapy. Curr Med Chem 12:319–338
3. Goodwin DA, Meares CF, McCall MJ, McTigue M, Chaovapong W (1988) Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J Nucl Med 29:226–234
4. Axworthy DB, Reno JM, Hylarides MD et al (2000) Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc Natl Acad Sci USA 97:1802–1807
5. Subbiah K, Hamlin DK, Pagel JM et al (2003) Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts. J Nucl Med 44:437–445